BenevolentAI
the benevolent platform empowers scientists with industry leading drug discovery comprehensive data foundations biology hypothesis driven target identification proprietary models reason across modal data to discover novel targets enables scientists to assess select only the most promising targets to take into wet lab experiments surfaces evidence to support higher con decisions data fed back into the knowledge graph to enhance future predictions | BenevolentAI
Company
Deck Type
Deck date
March 2023
Slide
7 of 38
Related slides by other companies
Investor Presentation
June 2021
Investor Presentation
March 2021
Investor Day
September 2022
SPAC
April 2021
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Investor Conference
January 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io